Export 315 results:
Author Keyword Title Type [ Year(Asc)]
Filters: First Letter Of Title is C  [Clear All Filters]
H. Wang, Wang, G., Billings, R., Li, D., Haase, S. R., Wheeler, P. F., Vance, D. E., and Li, W., Can Diet Supplements of Macular Pigment of Lutein, Zeaxanthin, and Meso-zeaxanthin Affect Cognition?, J Alzheimers Dis, vol. 87, no. 3, pp. 1079-1087, 2022.
C. Lachner, Day, G. S., Camsari, G. Balci, Kouri, N., Ertekin-Taner, N., Boeve, B. F., Labuzan, S. A., Lucas, J. A., E Thompson, A., Siddiqui, H., Crook, J. E., Cabrera-Rodriguez, J. N., Josephs, K. A., Petersen, R. C., Dickson, D. W., R Reichard, R., Mielke, M. M., Knopman, D. S., Graff-Radford, N. R., and Murray, M. E., Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old., J Alzheimers Dis, vol. 90, no. 1, pp. 405-417, 2022.
A. Morrow, Panyard, D. J., Deming, Y. K., Jonaitis, E., Dong, R., Vasiljevic, E., Betthauser, T. J., Kollmorgen, G., Suridjan, I., Bayfield, A., Van Hulle, C. A., Zetterberg, H., Blennow, K., Carlsson, C. M., Asthana, S., Johnson, S. C., and Engelman, C. D., Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation., J Alzheimers Dis, vol. 90, no. 2, pp. 667-680, 2022.
S. E. O'Bryant, Petersen, M., Hall, J., Johnson, L. A., Barber, R., Phillips, N., Braskie, M. N., Yaffe, K., Rissman, R., and Toga, A., Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites., J Alzheimers Dis, vol. 90, no. 2, pp. 905-915, 2022.
L. S. Nidadavolu, Feger, D., Wu, Y., Grodstein, F., Gross, A. L., Bennett, D. A., Walston, J. D., Oh, E. S., and Abadir, P. M., Circulating Cell-Free Genomic DNA Is Associated with an Increased Risk of Dementia and with Change in Cognitive and Physical Function., J Alzheimers Dis, vol. 89, no. 4, pp. 1233-1240, 2022.
A. A. Hosseini, Brown, T., Mannino, L., Gran, B., Junaid, K., and Mukaetova-Ladinska, E. B., Clinical Utility of Cerebrospinal Fluid Aβ42 and Tau Measures in Diagnosing Mild Cognitive Impairment in Early Onset Dementia., J Alzheimers Dis, vol. 87, no. 2, pp. 771-780, 2022.
S. Nabirotchkin, Bouaziz, J., Glibert, F., Mandel, J., Foucquier, J., Hajj, R., Callizot, N., Cholet, N., Guedj, M., and Cohen, D., Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 4, pp. 1585-1603, 2022.
J. Timsina, Gomez-Fonseca, D., Wang, L., Do, A., Western, D., Álvarez, I., Aguilar, M., Pastor, P., Henson, R. L., Herries, E., Xiong, C., Schindler, S. E., Fagan, A. M., Bateman, R. J., Farlow, M., Morris, J. C., Perrin, R., Moulder, K., Hassenstab, J., Chhatwal, J., Mori, H., Sung, Y. Ju, and Cruchaga, C., Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach., J Alzheimers Dis, vol. 89, no. 1, pp. 193-207, 2022.
H. Khodadadi, Salles, É. Lopes, Jarrahi, A., Costigliola, V., Khan, M. B., Yu, J. C., Morgan, J. C., Hess, D. C., Vaibhav, K., Dhandapani, K. M., and Baban, B., Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease., J Alzheimers Dis, vol. 80, no. 3, pp. 973-977, 2021.
A. M. Stickel, Tarraf, W., Gonzalez, K. A., Isasi, C. R., Kaplan, R., Gallo, L. C., Zeng, D., Cai, J., Pirzada, A., Daviglus, M. L., Goodman, Z. T., Schneiderman, N., and González, H. M., Central Obesity, Cardiometabolic Risk, and Cognitive Change in the Study of Latinos: Investigation of Neurocognitive Aging., J Alzheimers Dis, vol. 82, no. 3, pp. 1203-1218, 2021.
K. Kawamura, Miyajima, M., Nakajima, M., Kanai, M., Motoi, Y., Nojiri, S., Akiba, C., Ogino, I., Xu, H., Kamohara, C., Yamada, S., Karagiozov, K., Ikeuchi, T., Kondo, A., and Arai, H., Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus., J Alzheimers Dis, vol. 83, no. 1, pp. 179-190, 2021.
K. W. VanDusen, Li, Y. - J., Cai, V., Hall, A., Hiles, S., J Thompson, W., M Moseley, A., Cooter, M., Acker, L., Levy, J. H., Ghadimi, K., Quiñones, Q. J., Devinney, M. J., Chung, S., Terrando, N., Moretti, E. W., Browndyke, J. N., Mathew, J. P., and Berger, M., Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction., J Alzheimers Dis, vol. 80, no. 3, pp. 1281-1297, 2021.
J. Svensson, Blomqvist, M., Kettunen, P., Eckerström, C., Henricsson, M., Jonsson, M., Bjerke, M., Månsson, J. - E., and Wallin, A., Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia., J Alzheimers Dis, vol. 82, no. 2, pp. 781-790, 2021.
P. P. Chum, Hakim, M. A., and Behringer, E. J., Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model., J Alzheimers Dis, vol. 85, no. 1, pp. 91-113, 2021.
M. Chung, Rhee, H. Young, and Chung, W. Kuu, Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients., J Alzheimers Dis, vol. 80, no. 3, pp. 941-947, 2021.
A. A. Harb, Chen, R. J., Chase, H. S., Natarajan, K., and Noble, J. M., Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave., J Alzheimers Dis, vol. 81, no. 2, pp. 679-690, 2021.
L. C. Beishon, Panerai, R. B., Budgeon, C., Subramaniam, H., Mukaetova-Ladinska, E., Robinson, T. G., and Haunton, V. J., The Cognition and Flow Study: A Feasibility Randomized Controlled Trial of the Effects of Cognitive Training on Cerebral Blood Flow., J Alzheimers Dis, vol. 80, no. 4, pp. 1567-1581, 2021.
S. G. Ryman, Yutsis, M., Tian, L., Henderson, V. W., Montine, T. J., Salmon, D. P., Galasko, D., and Poston, K. L., Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology., J Alzheimers Dis, vol. 80, no. 3, pp. 1243-1256, 2021.
F. Yu, Vock, D. M., Zhang, L., Salisbury, D., Nelson, N. W., Chow, L. S., Smith, G., Barclay, T. R., Dysken, M., and Wyman, J. F., Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial., J Alzheimers Dis, vol. 80, no. 1, pp. 233-244, 2021.
J. Cummings, Schwartz, G. G., Nicholls, S. J., Khan, A., Halliday, C., Toth, P. P., Sweeney, M., Johansson, J. O., Wong, N. C. W., Kulikowski, E., Kalantar-Zadeh, K., Lebioda, K., Ginsberg, H. N., Winblad, B., Zetterberg, H., and Ray, K. K., Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial., J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
Y. Yamada, Shinkawa, K., Kobayashi, M., Caggiano, V., Nemoto, M., Nemoto, K., and Arai, T., Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment., J Alzheimers Dis, vol. 84, no. 1, pp. 315-327, 2021.
R. Squitti, Faller, P., Hureau, C., Granzotto, A., White, A. R., and Kepp, K. P., Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology., J Alzheimers Dis, vol. 83, no. 1, pp. 23-41, 2021.
A. Subotic, McCreary, C. R., Saad, F., Nguyen, A., Alvarez-Veronesi, A., Zwiers, A. M., Charlton, A., Beaudin, A. E., Ismail, Z., G Pike, B., and Smith, E. E., Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy., J Alzheimers Dis, vol. 81, no. 4, pp. 1663-1671, 2021.
A. Wimo, Belger, M., Bon, J., Jessen, F., Dumas, A., Kramberger, M. G., Jamilis, L., Johansson, G., Salas, A. Rodrigo, Gómez, O. Rodríguez, Sannemann, L., Stoekenbroek, M., Telleria, M. Gurruchaga, Valero, S., Vermunt, L., Waterink, L., Winblad, B., Visser, P. Jelle, Zwan, M., and Boada, M., A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project., J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.
R. R. Romano, Carter, M. A., Dietrich, M. S., Cowan, R. L., Bruehl, S. P., and Monroe, T. B., Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals., J Alzheimers Dis, vol. 79, no. 3, pp. 1227-1233, 2021.